Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Knowing when to start saving for retirement is essential for financial security. Explore the best timing for your savings plan.
24,441 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...
Three ETF filings aim to convert binary election outcomes into tradable funds, moving political bets from niche marke...
Dividend stocks paused last week as Crown Castle and AT&T tumbled while Coca-Cola rose. The move highlights a cooling...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...
Bitcoin’s rising hodl cohorts underscore a defensive market, with on-chain metrics showing persistent outflows, minim...
As MercadoLibre broadens beyond e-commerce, the mercado pago growth engine becomes a pivotal piece of the puzzle. Thi...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A major investment manager has built a sizable position in CCC Intelligent Solutions with a $15 million purchase. Thi...
Four high-profile tech names have shed 23% to 37% in 2026 as the Nasdaq edges higher. Analysts see substantial upside...
Oil futures surged Friday as traders priced in a higher chance of a U.S. strike on Iran after signals that diplomacy ...
As Middle East airspace remains closed amid tensions with Iran, carriers reroute flights and burn more fuel. Experts ...